Brenmiller Energy Ltd. (“Brenmiller”, “Brenmiller Energy” or the “Company”) (TASE: BNRG, Nasdaq: BNRG), a clean-energy company that provides Thermal Energy Storage (“TES”) systems to the global industrial and utility markets, today announced financial results as of and for the six months ended June 30, 2022 and operational updates.
Key Highlights
Management Commentary
“2022 is turning out to be a historic year for Brenmiller Energy,” said Avi Brenmiller, Chairman and Chief Executive Officer of Brenmiller Energy. “To date in 2022, we have reached many important milestones, including our first large commercial order for $9M with Philip Morris in Romania, the completion of a pilot project in Brazil with Fortlev, drawing from our credit facility with the European Investment Bank to accelerate work for our newly upgraded production facility, and the listing of our ordinary shares on the Nasdaq.”
“With the completion of our first pilot project in Brazil, and the near completion of others, including a utility scale project in Italy, we believe we are on the path to become one of the leading thermal energy storage solution providers, with a commercial ready solution,” continued Brenmiller. “As we look to the future, we believe there are many factors in our favor including the need for large industrial process companies and utilities to decarbonize their operations, high energy prices and an increased need for energy security. Our bGen TES system is well positioned to address these needs and we are optimistic that we will see an acceleration in converting our robust pipeline of opportunities into commercial orders throughout the remainder of 2022 and into 2023.”
Research and Development
Research, development, and engineering expenses were $2.47 million in the first half of 2022, compared to $1.90 million in the first half of 2021. The increase was primarily attributable to higher payroll costs as the Company has enhanced its research and development developments to support future growth.
Research, development, and engineering expenses, net breakdown:
Six months ended | ||
2022 | 2021 | |
USD in thousands (unaudited) | ||
Total research, development, and engineering expenses | 2,730 | 2,532 |
Less – grants | (263) | (634) |
Research, development and engineering expenses, net | 2,467 | 1,898 |
Balance Sheet Update
As of June 30, 2022, Brenmiller had cash and equivalents of $9.1 million. On May 24, 2022, the Company closed the second tranche of the investment by certain private investors pursuant to a securities purchase agreement dated October 29, 2021. As a result, the balance of $7.5 million in gross proceeds of the $15 million private placement has been paid to the Company by such investors against the issuance of the Company’s securities. On July 28, 2022, and as discussed in more detail below, Brenmiller made the first draw of 4.0 million euros from its 7.5 million euros credit facility with the European Investment Bank (“EIB”).
New Project Awards
In February 2022, Brenmiller signed a five-year framework agreement with Philip Morris Products SA (“Philip Morris”) for the supply of its TES systems. The framework agreement sets terms, with adjustments based on the size, for Brenmiller to provide its TES system, bGen, at forty-one of Philip Morris’ sites globally. Following the signing of the framework agreement with Philip Morris, on February 28, 2022, Brenmiller signed an agreement with Philip Morris Romania Romania S.R.L. for the purchase of a 31.5 MWh bGen unit in Romania for approximately $9.2 million, with an option to expand the capacity to 52.5 MWh. The Company is currently in early design stages and plans to begin construction in early 2023 with completion by the end of 2023.
On May 25, 2022, the Government Procurement Administration of Israel issued a notice regarding its intent to engage with Brenmiller as a sole supplier for the purchase of heat energy at Wolfson Hospital in Israel. Under the proposed engagement, Brenmiller will install its TES system, bGen, integrate it with the hospital’s local energy system and maintain the installed system. Brenmiller plans to enter into an approximately $5 million, seven and one-half year contract with Wolfson Hospital under which it will supply heat energy at prices to be agreed between the parties. This is Brenmiller’s first potential project using an Energy As a Service (EaaS) business model. Under this business model, profit margins are expected to be higher than those in a traditional capital equipment sale and be more recurring in nature.
Dimona Israel Production Facility
On March 31, 2021, Brenmiller signed a 7.5 million euros credit facility with the EIB for the creation of an advanced production facility in Dimona, Israel. The Company made its first draw down on the first of two tranches of the credit facility for 4.0 million euros on July 28, 2022.
The production facility is currently under construction and will have a capacity to produce up to 4,000 MWh per year of bGen thermal storage modules. The draw down on the EIB credit facility is a critical step in the Company meeting its target to reach full production capacity by the end of 2023. The Dimona production facility will play a meaningful role in Brenmiller’s effort to support current and potential future projects.
Operational Update
Brenmiller is currently in the process of installing pilot projects in various geographic regions in an effort to demonstrate the use of its technologies for both industrial and utility scale applications, which are ultimately expected to support the commercialization of the technology. Its pilot projects are progressing as planned and are expected to reach major milestones over the next twelve months. Key updates to its pilot projects include:
About Brenmiller Energy
Brenmiller Energy delivers scalable thermal energy storage solutions and services that allow customers to cost-effectively decarbonize their operations. Its patented bGen thermal storage technology enables the use of renewable energy resources, as well as waste heat, to heat crushed rocks to very high temperatures. They can then store this heat for minutes, hours, or even days before using it for industrial and power generation processes. With bGen, organizations have a way to use electricity, biomass and waste heat to generate the steam, hot water and hot air they need for a variety of applications, including, for example, to mold plastic, process food and beverages, produce paper, manufacture chemicals and pharmaceuticals or drive steam turbines without burning fossil fuels. For more information visit the company’s website at https://bren-energy.com/ and follow the company on Twitter and LinkedIn.
Cautionary Note Regarding Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. Statements that are not statements of historical fact may be deemed to be forward-looking statements. For example, the Company is using forward-looking statements in this press release when it discusses its expected timeline for installing and completing its pilot projects and reaching other milestones, its plans to enter into a contract with Wolfson Hospital to supply heat energy, and the role that the Company’s Dimona production facility will play to support current and potential future projects. Without limiting the generality of the foregoing, words such as "plan," "project," "potential," "seek," "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate" or "continue" are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect the Company's actual results and could cause such results to differ materially from any forward-looking statements that may be made in this press release. Factors that may affect the Company's results include, but are not limited to, the Company’s planned level of revenues and capital expenditures, the demand for and market acceptance of our products, impact of competitive products and prices, product development, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks and the risks associated with the adequacy of existing cash resources. The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's prospectus dated May 24, 2022 filed with the U.S. Securities and Exchange Commission (“SEC”), which is available on the SEC's website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION | |||
(Unaudited) | |||
June 30, | December 31, | ||
2022 | 2021 | ||
ASSETS | USD in thousands | ||
CURRENT ASSETS: | |||
Cash and cash equivalents | 9,144 | 8,280 | |
Restricted deposits | 42 | 47 | |
Trade receivables | 761 | 162 | |
Other receivables | 577 | 553 | |
Inventory | 327 | 95 | |
Assets held for sale (Rotem1) | 603 | - | |
TOTAL CURRENT ASSETS | 11,454 | 9,137 | |
NON-CURRENT ASSETS: | |||
Restricted deposits | 159 | 179 | |
Investment in joint venture | 40 | - | |
Right-of-use assets, net | 1,576 | 3,018 | |
Property, plant and equipment: | |||
Plant and equipment, net | 1,423 | 1,583 | |
Rotem 1 project | - | 679 | |
Total property, plant and equipment | 1,423 | 2,262 | |
TOTAL NON-CURRENT ASSETS | 3,198 | 5,459 | |
TOTAL ASSETS | 14,652 | 14,596 | |
LIABILITIES AND EQUITY | |||
CURRENT LIABILITIES: | |||
Short-term bank credit and loans | - | 5 | |
Trade payables | 71 | 264 | |
Deferred revenues | 260 | 1,095 | |
Other payables | 1,757 | 1,623 | |
Provisions | 215 | 215 | |
Current maturities of lease liabilities | 566 | 954 | |
TOTAL CURRENT LIABILITIES | 2,869 | 4,156 | |
NON-CURRENT LIABILITIES | |||
Lease liabilities | 1,113 | 2,448 | |
Liability for share options | 22 | 213 | |
Liability for royalties | 1,776 | 2,236 | |
TOTAL NON-CURRENT LIABILITIES | 2,911 | 4,897 | |
TOTAL LIABILITIES | 5,780 | 9,053 | |
EQUITY : | |||
Share capital | 88 | 79 | |
Share premium | 52,157 | 45,648 | |
Receipts on account of warrants | 1,832 | 1,176 | |
Capital reserve from transactions with controlling shareholders | 54,061 | 54,061 | |
Capital reserve on share based payments | 2,046 | 1,318 | |
Foreign currency cumulative translation reserve | (1,675) | (1,053) | |
Accumulated deficit | (99,637) | (95,686) | |
TOTAL EQUITY | 8,872 | 5,543 | |
TOTAL LIABILITIES AND EQUITY | 14,652 | 14,596 |
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS | |||
(Unaudited) | |||
Six months ended | |||
June 30 | |||
2022 | 2021 | ||
USD in thousands | |||
REVENUES | 1,520 | 285 | |
COSTS AND EXPENSES: | |||
COST OF REVENUES | (883) | (2,589) | |
RESEARCH, DEVELOPMENT AND ENGINEERING EXPENSES, NET | (2,467) | (1,898) | |
MARKETING AND PROJECT PROMOTION EXPENSES, NET | (612) | (355) | |
GENERAL AND ADMINISTRATIVE EXPENSES | (2,328) | (987) | |
SHARE IN LOSS OF JOINT VENTURE | (29) | - | |
OTHER INCOME (EXPENSES), NET | 38 | (293) | |
OPERATING LOSS | (4,761) | (5,837) | |
FINANCIAL INCOME | 964 | 788 | |
FINANCIAL EXPENSES | (154) | (135) | |
FINANCIAL INCOME, NET | 810 | 653 | |
LOSS FOR THE PERIOD | (3,951) | (5,184) | |
OTHER COMPREHENSIVE LOSS – ITEM THAT WILL NOT BE RECLASSIFIED TO PROFIT OR LOSS – EXCHANGE DIFFERENCES ON TRANSLATION TO PRESENTATION CURRENCY | (622) | (35) | |
COMPREHENSIVE LOSS FOR THE PERIOD | (4,573) | (5,219) | |
LOSS PER ORDINARY SHARE (in Dollars) - | |||
Basic and fully diluted loss | (0.28) | *(0.44) | |
*Retroactively adjusted to give effect to a reverse stock split of the Ordinary Shares – see Note 10A. |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | |||
(Unaudited) | |||
Six months ended | |||
June 30 | |||
2022 | 2021 | ||
USD in thousands | |||
CASH FLOWS - OPERATING ACTIVITIES: | |||
Net cash used for operating activities | (4,982) | (3,849) | |
CASH FLOWS - INVESTING ACTIVITIES: | |||
Purchase of equipment | (30) | (26) | |
Installation of production line | (108) | (96) | |
Investment in Joint venture | (74) | - | |
Restricted deposits, net | - | 3 | |
Net cash used for investing activities | (212) | (119) | |
CASH FLOWS - FINANCING ACTIVITIES: | |||
Proceeds from issuance of shares and warrants, net | 7,174 | 8,473 | |
Exercise of options and warrants | - | 20 | |
Repayment of bank loan and interest thereon | (5) | (8) | |
Payments with respect to lease liabilities and interest thereon | (284) | (383) | |
Repayment of royalties' liability | (24) | - | |
Grants recognized as liability for royalties | 28 | 40 | |
Repayment of shareholder's loan | - | (949) | |
Net cash provided by financing activities | 6,889 | 7,193 | |
NET INCREASE IN CASH AND CASH EQUIVALENTS | 1,695 | 3,225 | |
EXCHANGE DIFFERENCES ON CASH AND CASH EQUIVALENTS | (831) | (67) | |
CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE PERIOD | 8,280 | 2,278 | |
CASH AND CASH EQUIVALENTS AT THE END OF THE PERIOD | 9,144 | 5,436 |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | |||
- NET CASH USED FOR OPERATING ACTIVITIES | |||
Six months ended | |||
June 30 | |||
2022 | 2021 | ||
USD in thousands | |||
NET CASH USED FOR OPERATING ACTIVITIES | |||
Loss for the period | (3,951) | (5,184) | |
Adjustments for: | |||
Depreciation | 121 | 123 | |
Amortization of right-of-use assets | 273 | 181 | |
Loss from realization of equipment, metals and parts | - | 311 | |
Increase (Decrease) in research and development expenses due to royalty obligation | 86 | (40) | |
Provision | 24 | 673 | |
Share in loss of joint venture | 29 | - | |
Other income | (80) | - | |
Fair value adjustment of share options' liability | (178) | (745) | |
Other financial expenses | 46 | 72 | |
Share-based payment | 728 | 124 | |
(2,902) | (4,485) | ||
Changes in operating working capital: | |||
Increase in trade and other receivables | (709) | (246) | |
Decrease (increase) in inventory | (243) | 616 | |
Increase (decrease) in deferred revenues and trade and other payables | (1,128) | 266 | |
Net cash used for operating activities | (4,982) | (3,849) | |
NON-CASH INVESTMENT AND FINANCING ACTIVITIES: | |||
Recognition of Lease liability and right-of-use asset | 449 | 146 | |
Derecognition of lease liability | 1,512 | - | |
Derecognition of right of use asset | 1,432 | - | |
INTEREST PAYMENTS (included in financing items) | 33 | 16 |
Last Trade: | US$0.92 |
Daily Change: | 0.23 32.75 |
Daily Volume: | 187,341 |
Market Cap: | US$7.410M |
December 20, 2024 November 21, 2024 November 07, 2024 |
UGE International develops, owns, and operates commercial and community solar projects in the United States and strategic markets abroad. Our distributed energy solutions deliver cheaper, cleaner energy to businesses and consumers...
CLICK TO LEARN MOREElse Nutrition is changing the face of early childhood nutrition with clean, sustainable, plant-based products. The company has developed the world’s first whole plant-based infant formula that is targeting the $100+ billion global...
CLICK TO LEARN MORECOPYRIGHT ©2022 GREEN STOCK NEWS